Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 2
1993 1
1994 2
1996 3
1998 1
2000 3
2001 1
2002 3
2003 7
2004 3
2005 3
2006 3
2007 1
2008 5
2009 4
2010 5
2011 5
2012 6
2013 5
2014 4
2015 7
2016 8
2017 3
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Among authors: garbay jr. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Contrast-enhanced digital mammography.
Dromain C, Balleyguier C, Adler G, Garbay JR, Delaloge S. Dromain C, et al. Among authors: garbay jr. Eur J Radiol. 2009 Jan;69(1):34-42. doi: 10.1016/j.ejrad.2008.07.035. Epub 2008 Sep 13. Eur J Radiol. 2009. PMID: 18790584 Review.
Cutaneous melanoma.
Négrier S, Fervers B, Bailly C, Beckendorf V, Cupissol D, Doré JF, Dorval T, Garbay JR, Vilmer C; French National Federation of Cancer (FNCLCC). Négrier S, et al. Among authors: garbay jr. Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):81-5. doi: 10.1054/bjoc.2001.1771. Br J Cancer. 2001. PMID: 11355977 Free PMC article. No abstract available.
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.
van der Leij F, Bosma SC, van de Vijver MJ, Wesseling J, Vreeswijk S, Rivera S, Bourgier C, Garbay JR, Foukakis T, Lekberg T, van den Bongard DH, van Vliet-Vroegindeweij C, Bartelink H, Rutgers EJ, Elkhuizen PH. van der Leij F, et al. Among authors: garbay jr. Radiother Oncol. 2015 Mar;114(3):322-7. doi: 10.1016/j.radonc.2015.02.002. Epub 2015 Feb 17. Radiother Oncol. 2015. PMID: 25701298 Free article. Clinical Trial.
Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.
Balleyguier C, Dunant A, Ceugnart L, Kandel M, Chauvet MP, Chérel P, Mazouni C, Henrot P, Rauch P, Chopier J, Zilberman S, Doutriaux-Dumoulin I, Jaffre I, Jalaguier A, Houvenaeghel G, Guérin N, Callonnec F, Chapellier C, Raoust I, Mathieu MC, Rimareix F, Bonastre J, Garbay JR. Balleyguier C, et al. Among authors: garbay jr. J Clin Oncol. 2019 Apr 10;37(11):885-892. doi: 10.1200/JCO.18.00595. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811290 Clinical Trial.
[Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É. Jauffret C, et al. Among authors: garbay jr. Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. Gynecol Obstet Fertil. 2015. PMID: 26482833 French.
[Conformal accelerated partial breast irradiation: state of the art].
Acevedo-Henao CM, Heymann S, Rossier C, Garbay JR, Arnedos M, Balleyguier C, Ferchiou M, Marsiglia H, Bourgier C. Acevedo-Henao CM, et al. Among authors: garbay jr. Cancer Radiother. 2012 Oct;16(7):641-9. doi: 10.1016/j.canrad.2012.03.006. Epub 2012 Jun 21. Cancer Radiother. 2012. PMID: 22727723 Review. French.
Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Hélène C, Belichard C, Uzan S, Hudry D, Azuar P, Villet R, Penault Llorca F, Tunon de Lara C, Goncalves A, Esterni B; et al. Houvenaeghel G, et al. Among authors: garbay jr. Breast. 2014 Oct;23(5):561-6. doi: 10.1016/j.breast.2014.04.004. Epub 2014 May 27. Breast. 2014. PMID: 24874284 Free article.
81 results